Phase <scp>II</scp> Trial of Chemotherapy, Cetuximab, and Erlotinib in Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and NeckAarti Bhatia, Barbara Burtness|Head & Neck|2025Cited by 5
Phase II trial of chemotherapy, cetuximab and erlotinib in patients with metastatic or recurrent squamous cell carcinoma of the head and neckAarti Bhatia, Barbara Burtness|medRxiv|2025Cited by 2
1305 Coformulation of favezelimab and pembrolizumab as neoadjuvant therapy for resectable cutaneous squamous cell carcinoma (cSCC): Results from cohort a of the phase 2 keyform-010 studyMatteo S Carlino, Bella Nguyen, Ann W. Silk et al.|Unknown|2025Cited by 0